Press Releases

NxStage Joins Home Dialyzors United Conference to Drive More Awareness of Home Hemodialysis

LAWRENCE, Mass., Oct. 8, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer of NxStage, accepted Home Dialyzors United's (HDU) Trailblazer Award for NxStage's outstanding achievement in the innovation and advancement of home hemodialysis with the NxStage System One™, at the HDU's 3rd Annual Meet Up and Conference in Baltimore, MD.   In addition, Joseph E. Turk Jr., President of NxStage Medical, North America will highlight the growing adoption of the NxStage System One and preview the Company's Connected Health solution at the Conference on Tuesday, October 9th.

(Logo: )

HDU's 2012 Meet Up and Conference provides an opportunity for patients and care partners, who are looking for alternatives to in-center treatment, to learn firsthand from home dialyzors, care partners, and leading renal specialists about the improved quality of life and other benefits of more frequent home hemodialysis.

"We believe that home hemodialysis changes dialyzors' lives dramatically for the better, and at HDU we are driven to proactively advocate for issues to improve awareness and access," said Richard Berkowitz, founder and President of HDU.  "Thousands of dialyzors would not have the option to experience the benefits of daily home dialysis without the technology and ongoing commitment of NxStage.  HDU considers itself a true family of patients, care partners, professionals, and others with a shared vision, and we are delighted to recognize NxStage as part of this family."

"NxStage shares Home Dialyzors United passion to make home dialysis, specifically home hemodialysis, more accessible to patients with kidney failure.  We are delighted to be recognized for our commitment, and we look forward to productive future collaborations," said Jeffrey H. Burbank, Chief Executive Officer of NxStage.  "At the end of the day, patients want a better way for a better life.  We believe NxStage can help make that happen for tens of thousands of patients.  This conference is an important step toward helping many patients achieve those objectives."

HDU's 2012 Meet Up and Conference will be held October 7-10 in Baltimore, MD.  For more information on the conference, including a schedule of events, please visit

About the NxStage System One

The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA).  Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy.   When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand.  Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation.

About NxStage Medical

NxStage Medical, Inc. (NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2012. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Kristen K. Sheppard, Esq.
VP, Investor Relations

SOURCE NxStage Medical, Inc.